【友情提示】：本產(chǎn)品僅供科研研究使用，不得用于人體臨床直接檢測(cè)。避免給您帶來不必要的損失，請(qǐng)仔細(xì)閱讀購買說明！

產(chǎn)品名稱：α-Lapachone

CAS No.：4707-33-9

中文名：

別名：

分子式：C15H14O3

性狀：Yellow powder

純度：98.0%

特色優(yōu)勢(shì)：

1. 長(zhǎng)達(dá)16年對(duì)照品的專業(yè)**及標(biāo)準(zhǔn)制定

2. 高效穩(wěn)定純化技術(shù)-高速逆流色譜技術(shù)的運(yùn)用

3. 特有的高速逆流色譜對(duì)照品**中心及生產(chǎn)中心，保證對(duì)照品的質(zhì)量可控性及批量生產(chǎn)的穩(wěn)定性

4. 嚴(yán)格的質(zhì)量控制，通過**的檢測(cè)（1HNMR 13CNMR MS HPLC）

5. 部分對(duì)照品已獲得國(guó)家質(zhì)量監(jiān)督檢驗(yàn)檢疫總局頒發(fā)的標(biāo)準(zhǔn)物質(zhì)證書

6. 完善的庫存及供應(yīng)體系，所有產(chǎn)品均能現(xiàn)貨供應(yīng)

7. 高效的團(tuán)隊(duì)，99%的咨詢可即時(shí)回復(fù)

8. 已在瑞士、新加坡、泰國(guó)、韓國(guó)、比利時(shí)、西班牙等十三個(gè)國(guó)家設(shè)立代理商

9. 已成為國(guó)家標(biāo)準(zhǔn)實(shí)驗(yàn)室標(biāo)準(zhǔn)品制備分實(shí)驗(yàn)室。

標(biāo)準(zhǔn)物質(zhì)的特性分為五大類：

1、化學(xué)成分類：標(biāo)準(zhǔn)物質(zhì)，純的化合物或是有代表性的基體樣品，天然的或添加(被)分析物的(如，用作農(nóng)藥殘留分析的添加了殺蟲劑的動(dòng)物脂肪)，以一種或多種化學(xué)或物理化學(xué)特性值表征。

2、生物和臨床特性類：與目錄A相似的標(biāo)準(zhǔn)物質(zhì)，但以一種或多種生化或臨床特性值表征，如酶活性。

3、物理特性類：以一種或多種物理特性值表征的標(biāo)準(zhǔn)物質(zhì)，如熔點(diǎn)、粘性和密度。

4、工程特性類：以一種或多種工程特性值表征的標(biāo)準(zhǔn)物質(zhì)，如硬度、拉伸強(qiáng)度和表面特性。

5、其他特性。這些類別又被細(xì)分為三級(jí)子類，例如，在化學(xué)成分類中，以微量錳、硅、銅、鎳和鉻含量表征的鋁合金，列于化學(xué)成分一金屬一有色金屬一鋁合金的子類中；在化學(xué)成分類別中，標(biāo)準(zhǔn)物質(zhì)還可進(jìn)一步被分為單一成分的標(biāo)準(zhǔn)物質(zhì)和基體標(biāo)準(zhǔn)物質(zhì)兩大類；單一成分的標(biāo)準(zhǔn)物質(zhì)是純物質(zhì)(元素或化合物)，或純度、濃度、熔點(diǎn)、熔化焓值、粘度、紫外可見光吸光率、閃點(diǎn)等參考值已確定的純物質(zhì)的溶液；這類標(biāo)準(zhǔn)物質(zhì)的重要用途之一是分析儀器 的檢定或校準(zhǔn)。
訂購須知：

1.優(yōu)勢(shì)：高效穩(wěn)定的專業(yè)純化技術(shù)，完善的庫存及供應(yīng)體系，高效的銷售團(tuán)隊(duì)。

2.包裝規(guī)格：常規(guī)包裝，如有特殊需求，我們根據(jù)客戶要求包裝。

3.運(yùn)輸方式：默認(rèn)順豐快遞，大宗貨物走德邦物流。

4.質(zhì)量保證：嚴(yán)格的質(zhì)量控制，通過**的檢測(cè)，是質(zhì)量保證的基礎(chǔ)。如有異議經(jīng)我司確認(rèn)可無條件退換貨。

磷酸化表皮生長(zhǎng)因子受體抗體（石蠟切片需做抗原修復(fù)） 葉酸受體自身IgM抗體檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體 not yet tested in other applications.葉酸受體自身IgA抗體檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體 optimal dilutions/concentrations should be determined by the end user.  D-精氨酸檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. CD45分子檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. ?；o酶A脫氫酶檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Function : Binds to activated (phosphorylated) protein-Tyr kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Necessary for the insulin-stimulated increase in glucose uptake and glycogen synthesis in insulin-sensitive tissues. Plays an important role in signaling in response to FGFR1, FGFR2, FGFR3, FGFR4, KITLG/SCF, KIT, PDGFRA and PDGFRB. Likewise, plays a role in ITGB2 signaling.長(zhǎng)鏈脂酰基coA脫氫酶檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Subunit : Heterodimer of a regulatory subunit PIK3R1 and a p110 catalytic subunit (PIK3CA, PIK3CB or PIK3CD). Interacts with FER. Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated). Interacts with PTK2/FAK1. Interacts with phosphorylated TOM1L1. Interacts with phosphorylated LIME1 upon TCR and/or BCR activation. Interacts with SOCS7. Interacts with RUFY3. Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated). Interacts with LYN (via SH3 domain); this enhances enzyme activity. Interacts with phosphorylated LAT, LAX1 and TRAT1 upon TCR activation. Interacts with CBLB. Interacts with HIV-1 Nef to activate the Nef associated p21-activated kinase (PAK). This interaction depends on the C-terminus of both proteins and leads to increased production of HIV. Interacts with HCV NS5A. The SH2 domains interact with the YTHM motif of phosphorylated INSR in vitro. Also interacts with tyrosine-phosphorylated IGF1R in vitro. Interacts with CD28 and CD3Z upon T-cell activation. Interacts with IRS1 and phosphorylated IRS4, as well as with NISCH and HCST. Interacts with FASLG, KIT and BCR. Interacts with AXL, FGFR1, FGFR2, FGFR3 and FGFR4 (phosphorylated). Interacts with FGR and HCK. Interacts with PDGFRA (tyrosine phosphorylated) and PDGFRB (tyrosine phosphorylated). Interacts with ERBB4 (phosphorylated). Interacts with NTRK1 (phosphorylated upon ligand-binding).沙眼衣原體抗體檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Tissue Specificity : Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).阿黑皮素原檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Post-translational modifications : Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.膀胱腫瘤抗原檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear. Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.腺苷酸環(huán)化酶關(guān)聯(lián)蛋白2檢測(cè)試劑盒

磷酸化表皮生長(zhǎng)因子受體抗體Similarity : Belongs to the PI3K p85 subunit family.羧肽酶E檢測(cè)試劑盒

磷酸化轉(zhuǎn)錄接頭蛋白EP300抗體Contains 1 Rho-GAP domain.蛋白聚糖檢測(cè)試劑盒

磷酸化轉(zhuǎn)錄因子ELK1抗體Contains 2 SH2 domains.堿性成纖維生長(zhǎng)因子抗體檢測(cè)試劑盒

磷酸化轉(zhuǎn)錄因子ELK1抗體Contains 1 SH3 domain.甘油二酯檢測(cè)試劑盒
α-Lapachone標(biāo)準(zhǔn)品分子量：～27600

活力：≥150u/mg

活力定義：One unit will hydrolyze casein to produce 1ug of tyrosine per min at pH 10 at 40 °C

性狀(以下信息僅供參考)：棕褐色或淡褐色粉末

用途：本品僅供科研，不得用于其它用途。(以下用途僅供參考)用于蛋白質(zhì)水解

保存：-20℃

產(chǎn)品名稱：酸脫氫酶（兔?。?/span>

英文名稱：LAD；LDH；Lactic dehydrogenase(rabbit muscle)

其他名稱：L-酸脫氫酶；酸去氫酵素